Home
Medicines
Companies
COVID-19
Active Ingredients
Advanced Search
Adverse Event Reporting
Login
Search Medicine Database
Home
Medicines
Companies
COVID-19
More
expand_more
Login
menu
Home
Active Ingredients
Agalsidase beta
Agalsidase beta
Medicine
Status
PIL
SPC
XPIL
EDM - Patient
EDM - HCP
Legal Category
Active Ingredient(s)
Company
Fabrazyme 35 mg, powder for concentrate for solution for infusion
No Recent Update
PIL
28/06/21
SPC
28/06/21
No
EDM
08/04/21
EDM
08/04/21
A
Agalsidase beta
Sanofi Genzyme
Fabrazyme 5 mg, powder for concentrate for solution for infusion
No Recent Update
PIL
28/06/21
SPC
28/06/21
No
EDM
08/04/21
EDM
08/04/21
B
Agalsidase beta
Sanofi Genzyme
This medicine and its document have not been updated in the last 30 days.
Date of Update on Medicines.ie
Product subject to medical prescription which may not be renewed (A)
Product subject to medical prescription which may be renewed (B)
